Literature DB >> 33226516

Differential Wnt-β- catenin pathway activation in HPV positive and negative oral epithelium is transmitted during head and neck tumorigenesis: clinical implications.

Balarko Chakraborty1, Debalina Mukhopadhyay1, Anirban Roychowdhury1, Mukta Basu1, Neyaz Alam2, Kabita Chatterjee3, Jayanta Chakrabarti2, Chinmay Kumar Panda4.   

Abstract

The aim of this study is to understand the association of HPV infection and wnt-β-catenin self-renewal pathway in development of head and neck squamous cell carcinoma (HNSCC). For this reason, the molecular profiles (methylation/deletion/expression) of antagonists (SFRP1/2 and DKK1), agonists (FZD7 and LRP6) and effector protein β-catenin of the pathway were analyzed in HPV positive/negative oral epithelium at first, followed by its changes during development of the tumor along with correlations with different clinico-pathological parameters. HPV infection alone or in combination with tobacco habit could activate p- β-catenin expression in basal/parabasal layers of oral epithelium through high expression of FZD7 and significant down regulation of SFRP1/2 through promoter hypermethylation due to over expression of DNMT1 with ubiquitous down regulation of DKK1 and up-regulation of LRP6. This phenomenon has been seen in respective HPV positive and negative HNSCC tumors with additional deletion/microsatellite size alterations in the antagonists. Overall alterations (methylation/deletion) of SFRP1/2, DKK1 gradually increased from Group I (HPV-/Tobacco-) to Group IV(HPV+/Tobacco+) tumors, leading to the worst prognosis of the patients. Thus, the transmission of differentially activated wnt-β-catenin pathway from HPV positive/negative basal/parabasal layers of oral epithelium to HNSCC tumors determines differences in molecular pathogenesis of the disease.

Entities:  

Keywords:  Basal–parabasal layers; DKK1; E7; FZD7; HPV; Head and neck cancer; LRP6; Oral epithelium; SFRP1; SFRP2

Year:  2020        PMID: 33226516     DOI: 10.1007/s00430-020-00697-9

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  28 in total

1.  MYC gene amplification reveals clinical association with head and neck squamous cell carcinoma in Indian patients.

Authors:  N Bhattacharya; A Roy; B Roy; S Roychoudhury; C K Panda
Journal:  J Oral Pathol Med       Date:  2009-04-28       Impact factor: 4.253

Review 2.  HPV-mediated cervical carcinogenesis: concepts and clinical implications.

Authors:  Peter J F Snijders; Renske D M Steenbergen; Daniëlle A M Heideman; Chris J L M Meijer
Journal:  J Pathol       Date:  2006-01       Impact factor: 7.996

3.  Human papilloma virus (HPV) infection leads to the development of head and neck lesions but offers better prognosis in malignant Indian patients.

Authors:  Shreya Sarkar; Neyaz Alam; Jayanta Chakraborty; Jaydip Biswas; Syam Sundar Mandal; Susanta Roychoudhury; Chinmay Kumar Panda
Journal:  Med Microbiol Immunol       Date:  2017-03-25       Impact factor: 3.402

4.  HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.

Authors:  Cathy Ndiaye; Marisa Mena; Laia Alemany; Marc Arbyn; Xavier Castellsagué; Louise Laporte; F Xavier Bosch; Silvia de Sanjosé; Helen Trottier
Journal:  Lancet Oncol       Date:  2014-10-16       Impact factor: 41.316

Review 5.  Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC).

Authors:  Farshid Dayyani; Carol J Etzel; Mei Liu; Chung-Han Ho; Scott M Lippman; Anne S Tsao
Journal:  Head Neck Oncol       Date:  2010-06-29

6.  Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

Authors:  Rolando Herrero; Xavier Castellsagué; Michael Pawlita; Jolanta Lissowska; Frank Kee; Prabda Balaram; Thangarajan Rajkumar; Hema Sridhar; Barbara Rose; Javier Pintos; Leticia Fernández; Ali Idris; María José Sánchez; Adoración Nieto; Renato Talamini; Alessandra Tavani; F Xavier Bosch; Ulrich Reidel; Peter J F Snijders; Chris J L M Meijer; Raphael Viscidi; Nubia Muñoz; Silvia Franceschi
Journal:  J Natl Cancer Inst       Date:  2003-12-03       Impact factor: 13.506

7.  Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma.

Authors:  Yohei Sogabe; Hiromu Suzuki; Minoru Toyota; Kazuhiro Ogi; Takashi Imai; Masanori Nojima; Yasushi Sasaki; Hiroyoshi Hiratsuka; Takashi Tokino
Journal:  Int J Oncol       Date:  2008-06       Impact factor: 5.650

8.  SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit.

Authors:  Amlan Ghosh; Susmita Ghosh; Guru P Maiti; Mohammed G Sabbir; Neyaz Alam; Nilabja Sikdar; Bidyut Roy; Susanta Roychoudhury; Chinmay K Panda
Journal:  J Pathol       Date:  2009-02       Impact factor: 7.996

9.  Detection of human papilloma virus 16 and 18 DNA sequences by southern blot hybridization in oral leukoplakia and squamous cell carcinoma.

Authors:  Rahul Khanna; G R K Rao; S K Tiwary; Ashish Rai; Seema Khanna; A K Khanna
Journal:  Indian J Surg       Date:  2009-05-02       Impact factor: 0.656

10.  Human papillomavirus in the lesions of the oral mucosa according to topography.

Authors:  Marinka Mravak-Stipetić; Ivan Sabol; Josip Kranjčić; Marjana Knežević; Magdalena Grce
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

View more
  3 in total

1.  TCF3 Induces DNMT1 Expression to Regulate Wnt Signaling Pathway in Glioma.

Authors:  Wei Zeng; Haixiao Jiang; Ying Wang; Cunzu Wang; Bo Yu
Journal:  Neurotox Res       Date:  2022-04-21       Impact factor: 3.911

Review 2.  Human Papillomavirus and Cellular Pathways: Hits and Targets.

Authors:  Alessandro Medda; Daria Duca; Susanna Chiocca
Journal:  Pathogens       Date:  2021-02-25

3.  Expression of Tumor Suppressor SFRP1 Predicts Biological Behaviors and Prognosis: A Potential Target for Oral Squamous Cell Carcinoma.

Authors:  Chun Chen; Yifei Zhang; Yupeng Liu; Lei Hang; Jun Yang
Journal:  Biomolecules       Date:  2022-07-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.